Page last updated: 2024-08-21

oxazoles and Cardiomyopathy, Congestive

oxazoles has been researched along with Cardiomyopathy, Congestive in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hong, C; Kim, SJ; Liu, J; Molina, CA; Odashima, M; Sadoshima, J; Soler, S; Thaisz, J; Vatner, DE; Vatner, SF; Yamamoto, S; Yang, G; Yatani, A; Yehia, G; Zablocki, D1

Other Studies

1 other study(ies) available for oxazoles and Cardiomyopathy, Congestive

ArticleYear
Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy.
    The Journal of clinical investigation, 2003, Volume: 111, Issue:10

    Topics: Alkaloids; Animals; Apoptosis; Benzophenanthridines; Cardiomegaly; Cardiomyopathy, Dilated; Caspase 3; Caspases; Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; Genes, Dominant; Heart Ventricles; Marine Toxins; Mice; Mice, Transgenic; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Organ Specificity; Oxazoles; Phenanthridines; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; Transduction, Genetic

2003